播放中国国产国语纯一级黄片免费看, 大鸡吧快来啊阿啊阿啊黄片在线播放, 中文精品日韩网站在线观看视频免费, 别揉我奶头~嗯~啊~一区二区三区,AV无码播放一级毛片免费古装,亚洲春色一区二区三区,91大神极品,美国一级大黄一片免费下载,午夜爽爽爽男女免费观看软件

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-Amino-3,7-dihydro-2H-purin-2-one, also known as a nucleotide base, is an oxopurine derivative characterized by the substitution of an amino group at the 6th position of the 3,7-dihydro-purin-2-one structure. It is a white to light yellow crystal powder with significant applications in various industries due to its unique chemical properties.

3373-53-3

Post Buying Request

3373-53-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • China Largest factory Manufacturer Supply Highest Quality 6-Amino-3,7-dihydro-2H-purin-2-one CAS 3373-53-3

    Cas No: 3373-53-3

  • USD $ 2.0-6.0 / Kilogram

  • 1 Kilogram

  • 1000 Kilogram/Day

  • Leader Biochemical Group
  • Contact Supplier

3373-53-3 Usage

Uses

Used in Pharmaceutical Industry:
6-Amino-3,7-dihydro-2H-purin-2-one is used as an immunostimulator agent for enhancing the immune response in the body. Its role in stimulating the immune system makes it a valuable compound in the development of drugs targeting immune-related conditions and diseases.
Used in Chemical Research:
As a nucleotide base, 6-Amino-3,7-dihydro-2H-purin-2-one serves as an essential building block in the synthesis of various nucleotides and nucleic acids, which are crucial for genetic information storage and transmission in living organisms. Its use in chemical research contributes to the advancement of knowledge in molecular biology and the development of new therapeutic strategies.
Used in Diagnostic Applications:
6-Amino-3,7-dihydro-2H-purin-2-one's interaction with biological systems makes it a potential candidate for use in diagnostic applications, where it can be employed to detect or monitor specific biological processes or conditions related to immune function.

Synthesis Reference(s)

Journal of the American Chemical Society, 81, p. 2442, 1959 DOI: 10.1021/ja01519a042

Check Digit Verification of cas no

The CAS Registry Mumber 3373-53-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,7 and 3 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3373-53:
(6*3)+(5*3)+(4*7)+(3*3)+(2*5)+(1*3)=83
83 % 10 = 3
So 3373-53-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H5N5O/c6-3-2-4(8-1-7-2)10-5(11)9-3/h1-2H,(H3,6,7,8,9,10,11)

3373-53-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (I0370)  Isoguanine  >98.0%(HPLC)

  • 3373-53-3

  • 100mg

  • 690.00CNY

  • Detail

3373-53-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name isoguanine

1.2 Other means of identification

Product number -
Other names 6-amino-3,7-dihydro-purin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3373-53-3 SDS

3373-53-3Synthetic route

2-(methylthio)-7H-purin-6-amine
1198-83-0

2-(methylthio)-7H-purin-6-amine

isoguanine
3373-53-3

isoguanine

Conditions
ConditionsYield
With ethanol; dihydrogen peroxide
Multi-step reaction with 2 steps
1: chlorine; H2O
2: aq. NaOH solution
View Scheme
4,5,6-triamino-1H-pyrimidin-2-one
22715-34-0

4,5,6-triamino-1H-pyrimidin-2-one

isoguanine
3373-53-3

isoguanine

Conditions
ConditionsYield
With formic acid at 160℃;
2-methanesulfonyl-7(9)H-purin-6-ylamine
7357-53-1

2-methanesulfonyl-7(9)H-purin-6-ylamine

isoguanine
3373-53-3

isoguanine

Conditions
ConditionsYield
With sodium hydroxide
6-Amino-2-chlorpurin
1839-18-5

6-Amino-2-chlorpurin

isoguanine
3373-53-3

isoguanine

Conditions
ConditionsYield
With hydrogenchloride
5-amino-1(3)H-imidazole-4-carboxamidine dihydrochloride

5-amino-1(3)H-imidazole-4-carboxamidine dihydrochloride

isoguanine
3373-53-3

isoguanine

Conditions
ConditionsYield
With urea at 180℃;
With sodium hydroxide
8-chloro-2-ethoxy-6-amino-purine

8-chloro-2-ethoxy-6-amino-purine

isoguanine
3373-53-3

isoguanine

Conditions
ConditionsYield
With phosphonium iodide; hydrogen iodide at 30 - 40℃;
crotonoside

crotonoside

isoguanine
3373-53-3

isoguanine

Conditions
ConditionsYield
With sulfuric acid Hydrogenation;
2,8-dichloro-7(9)H-purin-6-ylamine
2914-09-2

2,8-dichloro-7(9)H-purin-6-ylamine

isoguanine
3373-53-3

isoguanine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: palladium/BaSO4; aq. NaOH solution
2: aqueous HCl
View Scheme
isoguanine
3373-53-3

isoguanine

xanthin
69-89-6

xanthin

Conditions
ConditionsYield
With genes from Klebsiella pneumoniae subsp. pneumoniae In aq. buffer at 30℃; pH=7.5; Kinetics; Temperature; Reagent/catalyst; Enzymatic reaction;
isoguanine
3373-53-3

isoguanine

6-amino-2-oxo-1H,7H-purin-3-ium chloride

6-amino-2-oxo-1H,7H-purin-3-ium chloride

Conditions
ConditionsYield
With hydrogenchloride In water
isoguanine
3373-53-3

isoguanine

A

1,N6-etheno-N9β-D-ribofuranosylisoguanosine

1,N6-etheno-N9β-D-ribofuranosylisoguanosine

B

1,N6-etheno-N7β-D-ribofuranosylisoguanosine

1,N6-etheno-N7β-D-ribofuranosylisoguanosine

C

1,N6-etheno-N6β-D-ribofuranosylisoguanosine

1,N6-etheno-N6β-D-ribofuranosylisoguanosine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogenchloride; sodium hydrogencarbonate / water / pH Ca. 2
2: ammonium hydroxide; calf spleen purine-nucleoside phosphorylase wild type / aq. buffer / 72 h / 30 °C / pH 7 / Enzymatic reaction
View Scheme
isoguanine
3373-53-3

isoguanine

1,N6-etheno-N6β-D-ribofuranosylisoguanosine

1,N6-etheno-N6β-D-ribofuranosylisoguanosine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydrogenchloride; sodium hydrogencarbonate / water / pH Ca. 2
2: ammonium hydroxide; calf spleen purine-nucleoside phosphorylase-N243D / aq. buffer / 72 h / 30 °C / pH 7 / Enzymatic reaction
View Scheme
2-chloroethanal
107-20-0

2-chloroethanal

isoguanine
3373-53-3

isoguanine

1,5,9-dihydro-9-oximidazo[1,2-a]purine

1,5,9-dihydro-9-oximidazo[1,2-a]purine

Conditions
ConditionsYield
With hydrogenchloride; sodium hydrogencarbonate In water pH=Ca. 2;

3373-53-3Relevant articles and documents

Regulation of xanthine oxidase activity by substrates at active sites via cooperative interactions between catalytic subunits: Implication to drug pharmacokinetics

Tai,Hwang

, p. 69 - 78 (2011)

Three xanthine oxidase substrates (i.e., xanthine, adenine, and 2-amino-4-hydroxypterin) show a "substrate inhibition" pattern (i.e., slower turnover rates at higher substrate concentrations), whereas another two substrates (i.e., xanthopterin and lumazine) show a "substrate activation" pattern (i.e., higher turnover rates at higher substrate concentrations). Binding of a 6-formylpterin at one of the two xanthine oxidase active sites slows down the turnover rate of xanthine at the adjacent active site from 17.0 s-1 to 10.5 s-1, and converts the V-[S] plot from "substrate inhibition" pattern to a classical Michaelis-Menten hyperbolic saturation pattern. In contrast, binding of xanthine at an active site accelerates the turnover rate of 6-formylpterin at the neighboring active site. The experimental results demonstrate that a substrate can regulate the activity of xanthine oxidase via binding at the active sites; or a xanthine oxidase catalytic subunit can simultaneously serve as a regulatory unit. Theoretical simulation based on the velocity equation derived from the extended Michaelis-Menten model shows that the substrate inhibition and the substrate activation behavior in the V-[S] plots could be obtained by introducing cooperative interactions between two catalytic subunits in homodimeric enzymes. The current work confirms that there exist very strong cooperative interactions between the two catalytic subunits of xanthine oxidase.

One-Step Synthesis of 2-Fluoroadenine Using Hydrogen Fluoride Pyridine in a Continuous Flow Operation

Salehi Marzijarani, Nastaran,Snead, David R.,McMullen, Jonathan P.,Lévesque, Fran?ois,Weisel, Mark,Varsolona, Richard J.,Lam, Yu-Hong,Liu, Zhijian,Naber, John R.

supporting information, p. 1522 - 1528 (2019/07/10)

We report the development of a one-pot synthesis of 2-fluoroadenine from an inexpensive 2,6-diaminopurine starting material using diazonium chemistry in a continuous fashion. Given the sensitivity of this transformation to temperature, we conducted critical experiments to study the exothermicity of the reaction and the heat removal, which were critical for the development of the process. Our goal was to improve the yield and purity of this pharmaceutical intermediate (2-fluoroadenine) and develop a more robust process.

Preparation of the 2′-deoxynucleosides of 2,6-diaminopurine and isoguanine by direct glycosylation

Arico, Joseph W.,Calhoun, Amy K.,McLaughlin, Larry W.

experimental part, p. 1360 - 1365 (2010/04/30)

Chemical Equetion Presentation The purine nucleoside 2,6-diaminopurine- 2′-deoxyriboside is prepared by the direct glycosylation of the 2,6-bis(tetramethylsuccinimide) derivative of the parent purine heterocycle 4 with 2-deoxy-3,5-di-O-(p-toluoyl)-α-D-erythro-pentofuranosyl chloride 5 using the sodium salt method. 2′-Deoxyisoguanosine is prepared from 2,6-diaminopurine by a five-step procedure. The purine heterocycle isoguanine is prepared by selective diazotization of 2,6-diaminopurine and then converted to the N9-trityl derivative to increase solubility. After silylation of the O 2-carbonyl with TMSCl, the N6-amino group is protected as the tetramethylsuccinimide (M4SI). The O2-carbonyl is protected as the DPC derivative, and the trityl group is removed. The resulting product is glycosylated in good yield to generate fully protected 2′-deoxyisoguanosine.

Purines. LXXIX. Synthesis and hydrolysis of 3-methoxyadenine and its N6-benzyl derivative leading to the corresponding 2-hydroxyadenines

Itaya, Taisuke,Kanai, Tae,Takada, Yasutaka,Kaneko, Miki,Yasuhara, Kensuke,Fujii, Tozo

, p. 554 - 556 (2007/10/03)

Methylation of adenine 3-oxide (8a) with MeI in AcNMe2 afforded 3- methoxyadenine (9a) in 44% yield. This compound (9a) underwent hydroxide-ion attack at the 2-position to give 2-hydroxyadenine (isoguanine) (10a) in 38% yield. A parallel reaction sequence starting from N6-benzyladenine 3-oxide (8c) and proceeding through N6-benzyl-3-methoxyadenine (9c) provided N6- benzyl-2-hydroxyadenine (10c) in 29% overall yield, together with a small amount of N6-benzyladenine (11c).

Oligonucleotides containing consecutive 2'-deoxyisoguanosine residues: Synthesis, duplexes with parallel chain orientation, and aggregation

Seela,Wei

, p. 73 - 85 (2007/10/03)

The 2'-deoxyisoguanosine phosphonates 3a and 4a and the phosphoramidites 3b and 4b were prepared as building blocks for solid-phase oligonucleotide synthesis. The diphenylcarbamoyl (dpc) residue was introduced as 2-oxo protecting group which stabilizes the N-glycosylic bond against hydrolysis and prevents the molecule from side reactions. The dpc-protected building blocks 4a,b were employed in solid-phase synthesis and were found to be much more efficient than the unprotected compounds 3a,b. Oligonucleotides with alternating (11) or consecutive isoguanine residues (13-15) were synthesized. They form duplexes with parallel chain orientation. The aggregate d(T4-iG4-T4) (15) containing four consecutive 2'-deoxyisoguanosine is shown to be a tetramer similar to that of d(T4-G4-T4).

A NOVEL AND EFFICIENT SYNTHESIS OF ISOGUANOSINE

Chern, Ji-Wang,Lee, Horng-Yuh,Huang, Min,Shish, Fang-Jy

, p. 2151 - 2154 (2007/10/02)

Isoguanosine (4b) was synthesized by a one-pot reaction involving a condensation of 5-amino-1-(β-D-ribofuranosyl)imidazole-4-carboxamide (1b) with benzoyl isothiocyanate, treatment of the resulting thiourea derivative with DCC furnished 5-(N1-benzoylcarbamoyl)aminoimidazole-4-carbonitrile (3b) which was then annulated with ethanolic ammonia to afford isoguanosine in a 68percent yield from 1b.

RING OPENING AND CLOSING REACTIONS OF IMIDAZOLES AND OTHER 1,3-DIAZAHETEROCYCLES WITH VINYL CHLOROFORMATE AND PHENYL CHLOROFORMATE

Pratt, R. F.,Kraus, K. K.

, p. 2431 - 2434 (2007/10/02)

Treatment of imidazole and benzimidazole with vinyl chloroformate or phenyl chloroformate in weakly alkaline aqueous solution leads to their conversion into the corresponding imidazol-2-ones; in weakly acidic solutions these chloroformates convert adenine into isoquanine, 6-methylaminopurine into 1-methylisoquanine and pyrimidine into an acyclic product.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3373-53-3